STABLE SOLIFENACIN PHARMACEUTICAL COMPOSITION CONTAINING SOLIFENACIN OR PHARMACEUTICAL ACCEPTABLE SALT THEREOF AND LACTOSE, AND METHOD FOR MANUFACTURING SAME

摘要

The present invention relates to a stable amorphous solifenacin pharmaceutical composition containing lactose as a stabilizer, a method for manufacturing the same, and a pharmaceutical composition for preventing or treating urologic diseases, respiratory diseases, or digestive diseases containing the same. The stable amorphous solifenacin pharmaceutical composition represents excellent thermal stability and can be prepared with uniform quality and high purity. Accordingly, the composition of the present invention can be efficiently used as an agent for preventing or treating the above-mentioned diseases.;COPYRIGHT KIPO 2016